Microneedling with glutathione versus microneedling alone in treatment of facial melasma: Split-face comparative study.
glutathione
melasma
microneedling
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
29
04
2023
received:
08
10
2022
accepted:
12
05
2023
medline:
4
12
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
ppublish
Résumé
Melasma is a distressing disfiguring acquired pigmentary disorder especially affecting females and it is of high tendency of recurrence. Up till now, treatment of melasma is a challenging problem. We evaluated the effectiveness of microneedling with glutathione versus microneedling alone in treatment of melasma. In this study, 29 adult females with epidermal type of melasma (confirmed with Wood's light examination) were enrolled. The affected area was subjected to microneedling using dermapen followed by application of glutathione solution on the right side only. This session was performed every 2 weeks for 3 months (six sessions for every patient). The response to therapy was measured using modified melasma area and severity index (m MASI) that were calculated on each side of the face (Hemi- m MASI) before treatment sessions. There was statistically significant reduction in the mean of Hemi- m MASI score over the sessions on both sides of the face but the right side (microneedling with glutathione) showed more reduction and earlier response to therapy than the left side (microneedling alone). On the left side, mean of Hemi- m MASI score before and after sessions was (4.06 ± 1.91, 2.31 ± 1.450) and on the right side, it was (4.21 ± 2.08, 1.96 ± 1.30), respectively and this was statistically significant. Percentage of improvement on the left side was 46.92 ± 16.30 (%) while on the right side was 55.17 ± 15.50 (%) and this was statistically significant. Microneedling is an effective promising tool in treatment of melasma and its combination with glutathione as a whitening agent, increases and accelerates its efficacy. So, combined therapy is more preferred than monotherapy in treatment of facial melasma.
Sections du résumé
BACKGROUND
BACKGROUND
Melasma is a distressing disfiguring acquired pigmentary disorder especially affecting females and it is of high tendency of recurrence. Up till now, treatment of melasma is a challenging problem.
OBJECTIVES
OBJECTIVE
We evaluated the effectiveness of microneedling with glutathione versus microneedling alone in treatment of melasma.
PATIENTS AND METHODS
METHODS
In this study, 29 adult females with epidermal type of melasma (confirmed with Wood's light examination) were enrolled. The affected area was subjected to microneedling using dermapen followed by application of glutathione solution on the right side only. This session was performed every 2 weeks for 3 months (six sessions for every patient). The response to therapy was measured using modified melasma area and severity index (m MASI) that were calculated on each side of the face (Hemi- m MASI) before treatment sessions.
RESULTS
RESULTS
There was statistically significant reduction in the mean of Hemi- m MASI score over the sessions on both sides of the face but the right side (microneedling with glutathione) showed more reduction and earlier response to therapy than the left side (microneedling alone). On the left side, mean of Hemi- m MASI score before and after sessions was (4.06 ± 1.91, 2.31 ± 1.450) and on the right side, it was (4.21 ± 2.08, 1.96 ± 1.30), respectively and this was statistically significant. Percentage of improvement on the left side was 46.92 ± 16.30 (%) while on the right side was 55.17 ± 15.50 (%) and this was statistically significant.
CONCLUSIONS
CONCLUSIONS
Microneedling is an effective promising tool in treatment of melasma and its combination with glutathione as a whitening agent, increases and accelerates its efficacy. So, combined therapy is more preferred than monotherapy in treatment of facial melasma.
Substances chimiques
Glutathione
GAN16C9B8O
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3379-3386Informations de copyright
© 2023 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Références
Neagu N, Conforti C, Agozzino M, et al. Melasma treatment: a systematic review. J Dermatol Treat. 2022;33:1-22.
Monisha B. A study of wood's lamp findings in melasma. Int J Dermatol Venereol Lepr Sci. 2021;4(2):18-21.
Mehrabi JN, Bar-Ilan E, Wasim S, et al. A review of combined treatments for melasma involvingenergy-based devices and proposed pathogenesis-oriented combinations. J Cosmet Dermatol. 2022;21:461-472.
Putra Gofur N, Putri Gofur A, Soesilaningtyas R, Kahdina M. Melasma risk factor and management: a review article. Clin Case Rep Clin Study. 2021;3(2):1-4.
McKesey J, Tovar-Garza A, Pandya A. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21(2):173-225.
Mekawy K, Sadek A, Seddeik A-HA. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split-face study. J Cosmet Dermatol. 2021;20(2):460-465.
Kumawat K, Bhatia J, Kataria R, Namdeo C, Sarin A. Comparative study of efficacy of intradermal tranexamic acid microinjections versus intradermal glutathione microinjections for treatment of facial melasma. Pigment Int. 2022;9(1):46.
Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the melasma area and severity index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(78-83):78-83.e2.
Budamakuntla L, Loganathan E, Suresh DH, et al. A randomised, open label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg. 2013;6(3):139-143.
Sansoni J, Hawthorne G, Marosszeky N, Moore K, Fleming G, Owen E. Validation and Clinical Translation of the Revised Continence and Patient Satisfaction Tools: Final Report. 2011 Centre for Health Service Development, University of Wollongong.
Iraji F, Nasimi M, Asilian A, Faghihi G, Mozafarpoor S, Hafezi H. Efficacy of mesotherapy with tranexamic acid and ascorbic acid with and without glutathione in treatment of melasma: a split face comparative trial. J Cosmet Dermatol. 2019;18:1416-1421.
Puri N. A study on the efficacy of mesotherapy using glutathione and vitamin C for the treatment of melasma. J Clinic Exper Cosme Derma. 2020;3:5.
Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016;82(3):262-272.
Bosamiya S, Jain S. A pilot study to compare therapeutic efficacy and safety of combined treatment of skin microneedling and depigmenting cream versus depigmenting cream alone in facial melasma at tertiary care center. J Cutan Aesthet Surg. 2021 Apr-Jun;14(2):156-159.
Fabbrocini G, De Vita V, Fardella N. Skin needling to enhance depigmenting serum penetration in the treatment of melasma. Plast Surg Int. 2011;2011:1-7.
Bagherani N, Smoller R. Efficacy of topical tranexmic acid in the treatment of melasma. Dermatol Ther. 2016;29(6):389-390.
Taher N, El-Sayed M, Bessar H. Efficacy of skin needling device versus placebo in treatment of melasma. The Egyptian J Hosp Med. 2021;85(1):2968-2972.
Farshi S, Mansouri P. Study of efficacy of microneedling and mesoneedling in the treatment of epidermal melasma: a pilot trial. J Cosmet Dermatol. 2020;19:1093-1098.
Iriarte C, Awosika O, Rengifo-Pardo M, Ehrlich A. Review of applications of microneedling in dermatology. Clin Cosmet Invest Dermatol. 2017;10:289-294.
Lima E. Microneedling in facial recalcitrant melasma: report of a series of 22 cases. An Bras Dermatol. 2015;90:919-921.